Sign in

What researchers published on Polymyalgia rheumatica

1,081 papers, newest first.

Showing 120 of 1,081

  • Analgesic prescribing in people with polymyalgia rheumatica: a retrospective cohort study in the Clinical Practice Research Datalink.Rheumatology advances in practice
  • Case report[Prednisone-responsive pure red cell aplasia associated with polymyalgia rheumatica].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Case report[68Ga]Ga-FAPI-46 PET/CT and [18F]FDG PET/CT in polymyalgia rheumatica, ovarian teratoma, and reactive peritoneal lesions: a case report.BJR case reports
  • Treatment patterns and outcomes of immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: a single-centre observational study.RMD open
  • Influence of Sex on Glucocorticoid Toxicity Profiles in Polymyalgia Rheumatica.ACR open rheumatology
  • ReviewMore is less: Glucocorticoid-sparing agents in polymyalgia rheumatica.Therapeutic advances in musculoskeletal disease
  • Single-cell transcriptome sequencing analysis of peripheral blood mononuclear cells reveals immune signatures in patients with polymyalgia rheumatica.Frontiers in immunology
  • Case report[A CASE OF POLYMYALGIA RHEUMATICA (PMR)-LIKE irAE DEVELOPING DURING NIVOLUMAB ADMINISTRATION AFTER SURGERY FOR MUSCLE-INVASIVE BLADDER CANCER : A CASE REPORT].Hinyokika kiyo. Acta urologica Japonica
  • ReviewEfficacy and Safety of Janus Kinase Inhibitors in Polymyalgia Rheumatica: A Systematic Review.Cureus
  • International recommendations for the use of imaging in the diagnosis and assessment of polymyalgia rheumatica.Annals of the rheumatic diseases
  • Conversion surgery after atezolizumab plus bevacizumab therapy for postoperative pulmonary metastasis of hepatocellular carcinoma complicated by polymyalgia rheumatica as an immune-related adverse event.Clinical journal of gastroenterology
  • Case reportPostoperative polymyalgia rheumatica after lung cancer resection in the absence of immune checkpoint inhibitors: A case report and literature review.Experimental and therapeutic medicine
  • JAK Inhibitors, Anti-IL-6R Antagonists, Secukinumab, Abatacept, and Rituximab in Polymyalgia Rheumatica: What Insights Emerge from Phase 2 and 3 Randomized Controlled Trials?Medicines (Basel, Switzerland)
  • Frailty characterization and patient-reported outcomes in patients with immune checkpoint inhibitor-related inflammatory arthritis and polymyalgia rheumatica.Rheumatology advances in practice
  • Targeted Therapies in Polymyalgia Rheumatica: From Immunopathophysiology to a Redefined Treatment Paradigm.Drugs
  • Meta-analysisOccurrence and clinical course of immune checkpoint inhibitor-associated inflammatory arthritis and polymyalgia rheumatica-like syndromes: a systematic review and meta-analysis.Frontiers in immunology
  • Beyond disease labels: towards a stratified spectrum model for giant cell arteritis and polymyalgia rheumatica.Rheumatology (Oxford, England)
  • Comment on:18F-fluorodeoxyglucose PET/CT uptake characteristics in ICI-induced polymyalgia rheumatica compared to idiopathic polymyalgia rheumatica.Clinical and experimental rheumatology
  • Therapeutic divergence between polymyalgia rheumatica and giant cell arteritis: lessons from IL-17A inhibition.Clinical and experimental rheumatology
  • GuidelineThe 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica.Rheumatology (Oxford, England)
  • ReviewA systematic literature review to inform the 2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis: management of disease including relapse and complications.EULAR rheumatology open
  • Imaging for diagnosis, monitoring and outcome prediction in polymyalgia rheumatica: a systematic literature review and meta-analysis informing an international task force.RMD open
  • Systematic literature review informing the 2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis: focus on referral and diagnosis.EULAR rheumatology open
  • ReviewElderly-onset rheumatoid arthritis versus polymyalgia rheumatica: A systematic review and meta-analysis on pathophysiology, diagnosis and clinical progression.Autoimmunity reviews
  • Plant-based diet quality and risk of giant cell arteritis and polymyalgia rheumatica: findings from the E3N prospective cohort study.European journal of nutrition
  • Is checkpoint inhibitors-induced polymyalgia rheumatica really polymyalgia rheumatica?Rheumatology (Oxford, England)
  • Cases Report: Prominent Distal Pitting Edema Resembling Remitting Seronegative Symmetrical Synovitis With Pitting Edema in the Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum: Diagnostic Value of Multimodal Imaging in Two Cases.International journal of rheumatic diseases
  • In recently relapsed polymyalgia rheumatica during GC tapering, secukinumab increased sustained remission rates at 1 y.Annals of internal medicine
  • Study on the implementation of the 2015 EULAR/ACR recommendations for polymyalgia rheumatica in clinical practice.RMD open
  • Case reportMetastatic melanoma presenting with paraneoplastic dermatomyositis mimicking polymyalgia rheumatica.BMJ case reports
  • Immune Cells and Polymyalgia Rheumatica: Insights from a Bidirectional Mendelian Randomization Analysis.Current medicinal chemistry
  • Impact of corticosteroid use on quality of life of people over 65 years of age with giant cell arteritis and/or polymyalgia rheumatica.Geriatric nursing (New York, N.Y.)
  • Serum protein biomarkers for polymyalgia rheumatica: a case-control study.Frontiers in immunology
  • Diagnosing polymyalgia rheumatica: rethinking musculoskeletal ultrasound.The Lancet. Rheumatology
  • Diagnostic accuracy of musculoskeletal ultrasound in suspected polymyalgia rheumatica: a multicentre, cohort study.The Lancet. Rheumatology
  • Shared and Distinguishing Features of Late-Onset Rheumatic Diseases Fulfilling Polymyalgia Rheumatica Classification Criteria.Arthritis & rheumatology (Hoboken, N.J.)
  • Orbital Inflammation can be visualized by black blood MRI in isolated polymyalgia rheumatica.Rheumatology (Oxford, England)
  • Efficacy and safety of tofacitinib in polymyalgia rheumatica: a retrospective comparative study.Scandinavian journal of rheumatology
  • Macrovascular damage in polymyalgia rheumatica: integrated vascular phenotyping in the POLYMYACARD cohort.Arthritis research & therapy
  • Incidence and Disease Course of Polymyalgia Rheumatica During Two Decades: A Nationwide Study Across Health Care Sectors in Denmark.Arthritis & rheumatology (Hoboken, N.J.)
  • ReviewBaseline comorbidity assessment may authorize early steroid-sparing therapy in older patients with polymyalgia rheumatica.Clinical rheumatology
  • Response to 'Correspondence on "Results of a 1-year randomized double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica" by Bolhuis TE et al'.Annals of the rheumatic diseases
  • Correspondence on 'Results of a 1-year randomised double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica' by Bolhuis et al.Annals of the rheumatic diseases
  • Choroidal thickness as a biomarker of inflammatory activity in patients with polymyalgia rheumatica receiving anti-IL-6 treatment.Frontiers in medicine
  • Review[Polymyalgia rheumatica].Zeitschrift fur Rheumatologie
  • Frailty Assessment in Polymyalgia Rheumatica: Comparative Performance and Determinants of Clinical-Research Frailty Assessment (CRAF) and Kihon Checklist (KCL) Scores.Journal of clinical medicine
  • Integration of Clinical, Cytokine, and Ultrasound Data Using Machine Learning Reveals a Multidimensional Inflammatory Signature in Polymyalgia Rheumatica.Journal of personalized medicine
  • Polymyalgia Rheumatica or Something Else? Bilateral Shoulder, Arm, and Thigh Pain with Diffuse Marrow Edema Revealing B-cell Acute Lymphoblastic Leukemia.Internal medicine (Tokyo, Japan)
  • Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica.RMD open
  • Recognising and managing polymyalgia rheumatica.BMJ (Clinical research ed.)
  • Increased optic nerve-region [18F]FDG uptake in clinically isolated polymyalgia rheumatica: an exploratory PET/CT study within the GCA-PMR spectrum.Frontiers in immunology
  • 2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis.Annals of the rheumatic diseases
  • Investigating the Causal Association Between Polymyalgia Rheumatica and Hypothyroidism Using Mendelian Randomization Analysis.Current rheumatology reviews
  • Case reportDurable Response to Durvalumab in Occult Small-Cell Lung Cancer With Immune Checkpoint Inhibitor-Related Inflammatory Arthritis With Polymyalgia Rheumatica-Like Features.Geriatrics & gerontology international
  • ReviewSmall-Molecule Strategies for Polymyalgia Rheumatica and Giant Cell Arteritis in Older Adults.Molecules (Basel, Switzerland)
  • The association of Neoehrlichia mikurensis infection with polymyalgia rheumatica.Infection
  • A rare clinical presentation of enterococcal aortic valve endocarditis mimicking polymyalgia rheumatica.Polish archives of internal medicine
  • Predictors of relapse, early escalation and 1-Year use of glucocorticoids in new-onset polymyalgia rheumatica: A prospective cohort study.Seminars in arthritis and rheumatism
  • A Delphi survey of patients and clinicians on a unified and stratified approach to managing GCA-PMR spectrum disease.Rheumatology (Oxford, England)
  • Plasma proteome differences between giant cell arteritis and polymyalgia rheumatica: a pilot study.Arthritis research & therapy
  • Rapid access strategies for polymyalgia rheumatica: current knowledge.EULAR rheumatology open
  • The distinct phenotype of subclinical giant cell arteritis in polymyalgia rheumatica: evidence from a PMR fast-track clinic.EULAR rheumatology open
  • Synovial Fluid Cell Profiling Identifies Distinct Inflammatory Phenotypes in Late-Onset Rheumatoid Arthritis and Polymyalgia Rheumatica.ACR open rheumatology
  • What cumulative glucocorticoid dose should trigger sparing strategies in polymyalgia rheumatica?Joint bone spine
  • Diagnostic accuracy of 18F-FDG PET-CT scores in distinguishing polymyalgia rheumatica from other inflammatory rheumatic diseases: a multicentre retrospective study (RHUMATEP).European journal of nuclear medicine and molecular imaging
  • Seronegative polymyalgia rheumatica: an update.Reumatologia
  • On the interpretation of validation in register-based identification of polymyalgia rheumatica.Scandinavian journal of rheumatology
  • Answer to: 'On the interpretation of validation in register-based identification of polymyalgia rheumatica' by Tanveer and Irfan.Scandinavian journal of rheumatology
  • Usefulness of 18F-FDG PET/CT to distinguish polymyalgia rheumatica in elderly patients presenting with myalgia.Clinical rheumatology
  • Direct interleukin-6 inhibitor olokizumab in the treatment of polymyalgia rheumatica: a case series.Frontiers in medicine
  • Trial resultEffect of supplemental hydrocortisone during stress in prednisolone-induced adrenal insufficiency: a study protocol for a multicentre, randomised, double-blinded, placebo-controlled clinical trial on health-related quality of life in patients with polymyalgia rheumatica/giant cell arteritis on low-dose prednisolone treatment (the RESCUE study).BMJ open
  • Lifetime risk of malignancy in polymyalgia rheumatica: a population-based matched cohort study from southern Norway.Rheumatology (Oxford, England)
  • Provision of Health Information to Australians With Polymyalgia Rheumatica: Patient Recall and Perceived Opportunities for Improvement.Musculoskeletal care
  • Experience of Australian rheumatologists managing polymyalgia rheumatica: results from a national survey.Internal medicine journal
  • Randomised trialPhase 3 Trial of Secukinumab in Polymyalgia Rheumatica.The New England journal of medicine
  • Emerging Era for Polymyalgia Rheumatica and GCA - Interleukin-17A Targeting.The New England journal of medicine
  • Polymyalgia Rheumatica. Reply.The New England journal of medicine
  • Polymyalgia Rheumatica.The New England journal of medicine
  • Polymyalgia Rheumatica.The New England journal of medicine
  • Case reportInflammation-Associated Microvascular Dysfunction in Polymyalgia Rheumatica: Reversible Capillary Impairment Documented in an Older Patient.Geriatrics & gerontology international
  • Prevalence and characteristics of subclinical polymyalgia rheumatica in patients with giant cell arteritis.Rheumatology (Oxford, England)
  • Observational studyComparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study.Journal for immunotherapy of cancer
  • ReviewTreatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids.Nature reviews. Rheumatology
  • Review[Polymyalgia rheumatica - frequent, but often overlooked].Deutsche medizinische Wochenschrift (1946)
  • Comment on: Recommendations of the German, Austrian and Swiss rheumatology and other medical societies for the management of polymyalgia rheumatica: reply.Rheumatology (Oxford, England)
  • Comment on: Recommendations of the German, Austrian and Swiss rheumatology and other medical societies for the management of polymyalgia rheumatica.Rheumatology (Oxford, England)
  • Magnetic resonance imaging of hand involvement in polymyalgia rheumatica: a comparison with seropositive rheumatoid arthritis.RMD open
  • ReviewThe management of rheumatic immune related adverse events.Best practice & research. Clinical rheumatology
  • Whole-body Dynamic [18F]FDG-PET/CT in Giant Cell Arteritis and Polymyalgia Rheumatica.Clinical nuclear medicine
  • ReviewTargeted small molecules in polymyalgia rheumatica: the emerging role of JAK inhibitors beyond glucocorticoids and DMARDs.Expert opinion on pharmacotherapy
  • Subacute-Onset Hypothyroidism in an Elderly Patient with Polymyalgia Rheumatica: A Case Report.The Tohoku journal of experimental medicine
  • Steroid-sparing strategies in polymyalgia rheumatica: a systematic review and meta-analysis of tocilizumab with practical guidance for tapering.BMC rheumatology
  • Periodontal inflammation in patients with polymyalgia rheumatica.Irish journal of medical science
  • Patient-reported outcome measures in incident Polymyalgia Rheumatica: Changes after treatment initiation, short-term glucocorticoid discontinuation, and at one-year follow-up.Seminars in arthritis and rheumatism
  • Superior correlation with clinical activity and unique detection patterns: a prospective study of FAPI versus FDG-PET in polymyalgia rheumatica and giant cell arteritis.European journal of nuclear medicine and molecular imaging
  • First profiling of the national Swiss Clinical Quality Management giant cell arteritis and polymyalgia rheumatica registry.Clinical and experimental rheumatology
  • Correction: The DANIsh VASculitis cohort study: protocol for a national multicenter prospective study including incident and prevalent patients with giant cell arteritis and polymyalgia rheumatica.Frontiers in medicine
  • Age and neutrophil counts at the time of diagnosis of polymyalgia rheumatica: are they useful or confounding factors in the geriatrician's clinical practice?European geriatric medicine
  • Observational study18F-fluorodeoxyglucose PET/CT uptake characteristics in immune checkpoint inhibitor-induced polymyalgia rheumatica compared to idiopathic polymyalgia rheumatica.Rheumatology (Oxford, England)
  • ReviewPET imaging of polymyalgia rheumatica: update and future trends.Seminars in nuclear medicine
  • Diagnosis and management practices in polymyalgia rheumatica among Turkish rheumatologists: An online cross-sectional survey.Northern clinics of Istanbul
  • In newly diagnosed polymyalgia rheumatica, weekly methotrexate improved glucocorticoid-free remission rates at 1 y.Annals of internal medicine
  • ReviewGlucocorticoid treatment in patients with inflammatory rheumatic diseases: current practice and open questions.The Lancet. Rheumatology
  • A Case of Pulmonary Asbestosis Presenting with Polymyalgia Rheumatica: A Case Report.Internal medicine (Tokyo, Japan)
  • Lower C-Reactive Protein and Preserved Cortisol Levels at Disease Onset Are Associated With Favorable Short-Term Prognosis in Polymyalgia Rheumatica.International journal of rheumatic diseases
  • Clinical Profile of Giant Cell Arteritis and Polymyalgia Rheumatica in a Tertiary Care Hospital in South India.Cureus
  • Case reportNew-onset of polymyalgia rheumatica in an elderly patient with calcium pyrophosphate deposition (CPPD) disease.Fukushima journal of medical science
  • Can artificial intelligence be used to write research protocols on polymyalgia rheumatica?Joint bone spine
  • Rheumatologist assessment in established polymyalgia rheumatica.Rheumatology (Oxford, England)
  • Regarding the Prognostic Value of the HALP Score in Giant Cell Arteritis and Polymyalgia Rheumatica.International journal of rheumatic diseases
  • Effectiveness and safety of sarilumab in polymyalgia rheumatica: A retrospective study of the FIRST registry.Modern rheumatology
  • Digital interventions for improving quality of life and physical function in adults aged 50 and over living with rheumatic and musculoskeletal diseases.The Cochrane database of systematic reviews
  • ReviewImmune checkpoint inhibitor-induced joint involvement.Presse medicale (Paris, France : 1983)
  • Assessing disease activity in polymyalgia rheumatica using the systemic immune-inflammation index: A retrospective cross-sectional study.Clinical rheumatology
  • Positive predictive value of a register-based method to identify polymyalgia rheumatica in primary and secondary care: a validation study in Denmark.Scandinavian journal of rheumatology
  • Observational studyRheumatic immune-related adverse effects of immune checkpoint treatment: a retrospective multicentre study.Scientific reports
  • ReviewPolymyalgia Rheumatica.The New England journal of medicine
  • Case reportMethotrexate Toxicity Management in Polymyalgia Rheumatica: A Case Report.Journal of community hospital internal medicine perspectives
  • Observational studyGiant cell arteritis-polymyalgia rheumatica spectrum disease (GPSD): Relation with neoplasms and possible role as a paraneoplastic syndrome.Reumatologia clinica
  • Calprotectin and serum amyloid A for disease activity assessment in giant cell arteritis and polymyalgia rheumatica: results from a prospective single-centre cohort study.Rheumatology international